NATUREX : Number of shares and voting rights as of February 28, 2011

le
0

Au 28.02.2011

 

Total number of outstanding shares forming the capital 4,959,935 ordinary shares under ISIN FR0000054694 1,450,996 preferred shares under ISIN FR0010833251 6,410,931
Total number of outstanding shares forming the capital
with voting rights 4,959,935 ordinary shares under ISIN FR0000054694 0 shares from stock-options under ISIN FR0000054694
4,959,935
Number of shares with double voting rights 86,947
Total number of gross voting rights 5,046,882
Number of shares without voting rights 7,000 registered shares 2,632 bearer shares in the frame of the liquidity contract  
Total number of exercisable voting rights* 5,037,250

*Real number of voting rights = total number of voting rights - number of shares without voting rights.

If you would like to receive financial information about Naturex by e-mail, go to : www.naturex.fr

NATUREX has been listed on segment B of NYSE Euronext Paris since October 1996

 

Number of shares in the capital : 6,410,931

4,959,935 ordinary shares (ISIN FR0000054694) 1,450,996 preferred shares(ISIN FR0000010833251)

Naturex is part of the following indexes :
SBF250, CAC All Shares, CAC Mid&Small 190, CAC Small 90, Gaïa Index
Naturex is eligible for the "long-only" DSS on NYSE Euronext Paris.

MNEMO: NRX - Reuters: NATU.PA - Bloomberg: NRX:FP

About Naturex

Naturex is the global leader in speciality plant-based natural ingredients.

The Group, organised around three strategic markets - Food & Beverage, Nutrition & Health and Personal Care - produces and markets specialty plant-based natural ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries.

Naturex's head office is based in Avignon. The company employs more than 950 people and has high-performance industrial resources through its 11 industrial sites in Europe (France, Italy, Spain, the United Kingdom and Switzerland), as well as in Morocco, the United States, Brazil and Australia. It also benefits from sales presence around the world through a dedicated network in 16 countries (France, Italy, Spain, the United Kingdom, Belgium, Germany, Switzerland, Russia, U.A.E., Thailand, Singapore, Japan, China, Australia, the United States and Brazil).

Naturex's sound performance is linked to the fast-growing demand for natural products and its capacity to provide manufacturers with the personalised means to meet the requirements of their end consumers. The Group's strength lies in its ability to position itself on specific products which constitute niche markets, thanks to sustained Research & Development.

Naturex Contacts
Jacques Dikansky
Chairman and CEO
Tel.: +33 (0)4 90 23 96 89
naturex@naturex.com
Thierry Lambert
Vice-Chairman and CFO
Tel.: +33 (0)4 90 23 96 89
t.lambert@naturex.com
Carole Alexandre
Investor Relations
Tel.: +33 (0)4 90 23 78 28
c.alexandre@naturex.com
Contacts Actus Finance
Anne Catherine Bonjour
Actus Press Relations
Tel.: +33 (0)1 53 67 36 93
acbonjour@actus.fr
Jérôme Fabreguettes-Leib
Investor Relations
Tel.: +33 (0)1 77 35 04 36
jfl@actus.fr
Information réglementée
Information relative au nombre total de droits de vote et d'actions composant le capital :
- Communiqué intégral et original au format PDF :
http://www.actusnews.com/documents_communiques/ACTUS-0-22891-cp-naturex-en-03032011.pdf © Copyright Actusnews Wire
Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur www.actusnews.com
Receive by email the next press releases of the company by registering on www.actusnews.com, it's free

Valeur associée
  Libellé Bourse Dernier Var. Vol.
Vous devez être membre pour ajouter des commentaires.
Devenez membre, ou connectez-vous.
Aucun commentaire n'est disponible pour l'instant